7 June 2018 - PrEP availability may play a part in men’s complacency about the chances of becoming infected, study suggests. ...
21 March 2018 - The Australian Government is taking a critical step in helping end the transmission of HIV infection in ...
20 October 2017 - Providing pre-exposure prophylaxis treatment to men who have sex with men at high risk of contracting ...
30 August 2016 - The TGA has approved Gilead's combination product for HIV-1 infection Odefsey. ...
12 September 2016 - Janssen today announced the submission of a Marketing Authorisation Application to the EMA, seeking approval for ...
9 September 2016 - PHARMAC is seeking feedback on a proposal to list a new treatment for HIV, dolutegravir (Tivicay) and ...
24 August 2016 - CADTH is in favour of the reimbursement of Gilead's new dual combination product for HIV-1 infection. ...
24 August 2016 - The recommendation comes with conditions. ...
23 August 2016 - The combination HIV medicines that has led to a significant drop in the number of HIV cases ...
22 August 2016 - Truvada is the first anti-retroviral medicine to be licensed in Europe for pre-exposure prophylaxis, in combination with ...
19 August 2016 - An expensive combination product that prevents people from getting HIV won't be funded by taxpayers in Australia ...
15 August 2016 - Deviation from the appropriate comparator therapy/higher loss for certain patients. ...
2 August 2016 - PHARMAC is pleased to announce the approval of an agreement with Merck Sharpe and Dohme (New Zealand) ...
22 July 2016 - Truvada to enhance existing HIV prevention strategies. ...
18 July 2016 - Data show Prezista is a safe and effective treatment option in pregnant women, with no reports of ...